Literature DB >> 3940220

Potentiation of antitumor activity of 1-phthalidyl 5-fluorouracil by acetazolamide.

H Kasai, K Tonda, M Hirata.   

Abstract

The effect of acetazolamide (A.A.) on the antineoplastic activity of 1-phthalidyl 5-fluorouracil (PH-FU) against rat and mouse solid tumors was examined. A.A., an inhibitor of liver PH-FU hydrolase, had no antitumor activity but greatly enhanced the activity of PH-FU when coadministered. The potentiation was evaluated in terms of suppression of tumor growth and prolongation of the life-span of tumor-bearing animals. Studies also revealed that A.A. elevated the concentration of PH-FU in tumor tissues, where 5-fluorouracil is slowly liberated from PH-FU. The results are consistent with the hypothesis that A.A. prevents enzymic degradation of PH-FU in the liver and promotes its distribution into target organs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940220     DOI: 10.1007/bf00255286

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  10 in total

1.  Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14.

Authors:  K L MUKHERJEE; C HEIDELBERGER
Journal:  J Biol Chem       Date:  1960-02       Impact factor: 5.157

2.  5-Fluorouracil derivatives. IV. Synthesis of antitumor-active acyloxyalkyl-5-fluorouracils.

Authors:  S Ozaki; Y Watanabe; T Hoshiko; H Mizuno; K Ishikawa; H Mori
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-02       Impact factor: 1.645

3.  Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivatives.

Authors:  T Kametani; K Kigasawa; M Hiiragi; K Wakisaka; K Nakazato; K Ichikawa; K Fukawa; O Irino; N Nishimura; T Okada
Journal:  J Med Chem       Date:  1982-10       Impact factor: 7.446

4.  A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytes.

Authors:  F Mentre; J L Steimer; J P Sommadossi; R B Diasio; J P Cano
Journal:  Biochem Pharmacol       Date:  1984-09-01       Impact factor: 5.858

5.  Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.

Authors:  J Fried; A G Perez; J M Doblin; B D Clarkson
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

6.  Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.

Authors:  J A Benvenuto; K Lu; S W Hall; R S Benjamin; T L Loo
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

7.  Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.

Authors:  R I Glazer; L S Lloyd
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

8.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

9.  Drug interactions in biotransformation of 1-phthalidyl 5-fluorouracil to 5-fluorouracil in rat liver.

Authors:  M Hirata; K Tonda
Journal:  Chem Biol Interact       Date:  1984-12       Impact factor: 5.192

10.  Mechanism of cytotoxic activity of 5'-deoxy-5-fluorouridine.

Authors:  R D Armstrong; K M Connolly; A M Kaplan; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.